mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.004 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.004 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.005 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
0.15 |
0.005 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.007 |